Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function |
Choi, Sungim
(Department of Infectious Diseases, Dongguk University Ilsan Hospital)
Choi, Heun (Department of Infectious Diseases, National Health Insurance Service Ilsan Hospital) Park, Seong Yeon (Department of Infectious Diseases, Dongguk University Ilsan Hospital) Kwak, Yee Gyung (Department of Internal Medicine, Inje University Ilsan Paik Hospital) Song, Je Eun (Department of Internal Medicine, Inje University Ilsan Paik Hospital) Shin, So Youn (Department of Infectious Diseases, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University) Baek, Ji Hyeon (Division of Infectious Diseases, Department of Internal Medicine, Inha University School of Medicine) Shin, Hyun-IL (Division of Vectors and Parasitic Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency) Oh, Hong Sang (Division of Infectious Disease, Department of Internal Medicine, Armed Forces Capital Hospital) Kim, Yong Chan (Department of Internal Medicine, Division of Infectious Disease, Yongin Severance Hospital, Yonsei University College of Medicine) Yeom, Joon-Sup (Department of Internal Medicine, Division of Infectious Disease, Yongin Severance Hospital, Yonsei University College of Medicine) Han, Jin-Hee (Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University) Kim, Min Jae (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Marcsisin SR, Reichard G, Pybus BS. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art. Pharmacol Ther 2016; 161: 1-10. https://doi.org/10.1016/j.pharmthera.2016.03.011 DOI |
2 | Chai JY. History and current status of malaria in Korea. Infect Chemother 2020; 52: 441-452. https://doi.org/10.3947/ic.2020.52.3.441 DOI |
3 | Potter BM, Xie LH, Vuong C, Zhang J, Zhang P, Duan D, Luong TL, Bandara Herath HM, Dhammika Nanayakkara NP, Tekwani BL, Walker LA, Nolan CK, Sciotti RJ, Zottig VE, Smith PL, Paris RM, Read LT, Li Q, Pybus BS, Sousa JC, Reichard GA, Marcsisin SR. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics. Antimicrob Agents Chemother 2015; 59: 2380-2387. https://doi.org/10.1128/AAC.00015-15 DOI |
4 | Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy WF, Deye G, Melendez V, Ockenhouse CF. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med 2013; 369: 1381-1382. https://doi.org/10.1056/NEJMc1301936 DOI |
5 | Martin Ramirez A, Lombardia Gonzalez C, Soler Maniega T, Gutierrez Liarte A, Domingo Garcia D, Lanza Suarez M, Bernal Fernandez MJ, Rubio JM. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function. Malar J 2020; 19: 259. https://doi.org/10.1186/s12936-020-03326-1 DOI |
6 | Goo YK, Ji SY, Shin HI, Moon JH, Cho SH, Lee WJ, Kim JY. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea. PLoS One 2014; 9: e97390. https://doi.org/10.1371/journal.pone.0097390 DOI |
7 | Baird JK, Louisa M, Noviyanti R, Ekawati L, Elyazar I, Subekti D, Chand K, Gayatri A, Instiaty, Soebianto S, Crenna-Darusallam C, Djoko D, Hasto BD, Meriyenes D, Wesche D, Nelwan EJ, Sutanto I, Sudoyo H, Setiabudy R. Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria. JAMA Netw Open 2018; 1: e181449. https://doi.org/10.1001/jamanetworkopen.2018.1449 DOI |
8 | Im JH, Huh K, Yoon CG, Woo H, Lee JS, Chung MH, Klein TA, Jung J. Malaria control and chemoprophylaxis policy in the Republic of Korea Armed Forces for the previous 20 years (1997- 2016). Malar J 2018; 17: 1-9. https://doi.org/10.1186/s12936-018-2449-4 DOI |
9 | de Araujo FCF, De Rezende AnM, Fontes CJF, Carvalho LH, de Brito CFAJPo. Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection. PLoS One 2012; 7: e49871. https://doi.org/10.1371/journal.pone.0049871 DOI |
10 | Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis 2007; 195: 927-933. https://doi.org/10.1086/512241 DOI |
11 | Tagariello G, Sartori R, Inojosa WO, Candiotto L, Radossi P, Scarpa E, Tassinari C. Dramatic post-splenectomy onset of malaria caused by latent Plasmodium vivax in a female immigrant with severe immunological anaemia. Blood Transfus 2014; 12: 428-430. https://doi.org/10.2450/2014.0242-13 DOI |
12 | Kho S, Andries B, Poespoprodjo JR, Commons RJ, Shanti PAI, Kenangalem E, Douglas NM, Simpson JA, Sugiarto P, Anstey NM, Price RN. High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia. Clin Infect Dis 2019; 68: 51-60. https://doi.org/10.1093/cid/ciy403 DOI |
13 | Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haidar CE, Klein TE, Gammal RS, Relling MV, Scott SA, Hertz DL, Guchelaar HJ, Gaedigk A. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and dutch pharmacogenetics working group. Clin Transl Sci 2020; 13: 116-124. https://doi.org/10.1111/cts.12692 DOI |
14 | US Food and Drug Administration. Clinical drug interaction studies-Cytochrome P450 enzyme-and transporter-mediated drug interactions guidance for industry, January 2020 [Internet]; [cited 2020 June 5]. Available from: https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/clinical-druginteraction-studies-cytochrome-p450-enzyme-and-transportermediated-drug-interactions |
15 | Schmidt LH, Fradkin R, Vaughan D, Rasco J. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose. Am J Trop Med Hyg 1977; 26: 1116-1128. https://doi.org/10.4269/ajtmh.1977.26.1116 DOI |
16 | Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, White NJ, Snounou G. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J 2005; 4: 20. https://doi.org/10.1186/1475-2875-4-20 DOI |
17 | Mat Salleh NH, Rahman MFA, Samsusah S, De Silva JR, Ng DC, Ghozali AH, Tan JH, Lai MY, Amir A, Liew JWK, Lau YL. Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia. Trans R Soc Trop Med Hyg 2020; 114: 700-703. https://doi.org/10.1093/trstmh/traa042 DOI |
![]() |